← Back to Dashboard

Oritavancin

Transglycosylation; transpeptidation and cell membrane interaction/disruption inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC1C(C(CC(O1)OC2C3C(=O)NC(C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)C(C(=O)N3)N…
VHFGEBVPHAGQPI-LXKZPTCJSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus6

Zaire ebolavirus
EBOV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:26953343
Hepacivirus C
HCV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Ref
Human metapneumovirus
HMPV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Ref
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:26953343
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:29698664
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:26953343